X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Sterling Biotech with MYLAN INC. - US - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STERLING BIOTECH vs MYLAN (US) - Comparison Results

STERLING BIOTECH    Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 STERLING BIOTECH   MYLAN
EQUITY SHARE DATA
    STERLING BIOTECH
Dec-13
MYLAN
Dec-14
STERLING BIOTECH/
MYLAN
5-Yr Chart
Click to enlarge
High Rs113,861-   
Low Rs32,721-   
Sales per share (Unadj.) Rs26.81,321.7-  
Earnings per share (Unadj.) Rs-15.0159.2-  
Cash flow per share (Unadj.) Rs-5.5256.3-  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs54.9657.0-  
Shares outstanding (eoy) m267.87378.37-   
Bonus/Rights/Conversions -OI-  
Price / Sales ratio x0.32.5 10.4%   
Avg P/E ratio x-0.520.7 -2.2%  
P/CF ratio (eoy) x-1.312.8 -9.9%  
Price / Book Value ratio x0.15.0 2.5%  
Dividend payout %00-   
Avg Mkt Cap Rs m1,8621,245,149 0.1%   
No. of employees `0001.425.0 5.4%   
Total wages/salary Rs m5470-   
Avg. sales/employee Rs Th5,303.320,004.1 26.5%   
Avg. wages/employee Rs Th403.80-   
Avg. net profit/employee Rs Th-2,959.02,409.8 -122.8%   
INCOME DATA
Net Sales Rs m7,181500,102 1.4%  
Other income Rs m43-2,915 -1.5%   
Total revenues Rs m7,223497,187 1.5%   
Gross profit Rs m947124,378 0.8%  
Depreciation Rs m2,54336,730 6.9%   
Interest Rs m4,37721,572 20.3%   
Profit before tax Rs m-5,93163,161 -9.4%   
Minority Interest Rs m0-259 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-1,9242,656 -72.5%   
Profit after tax Rs m-4,00760,245 -6.7%  
Gross profit margin %13.224.9 53.0%  
Effective tax rate %32.44.2 771.6%   
Net profit margin %-55.812.0 -463.2%  
BALANCE SHEET DATA
Current assets Rs m14,335439,655 3.3%   
Current liabilities Rs m49,809343,723 14.5%   
Net working cap to sales %-494.019.2 -2,575.4%  
Current ratio x0.31.3 22.5%  
Inventory Days Days40378 516.7%  
Debtors Days Days171107 159.1%  
Net fixed assets Rs m55,432115,697 47.9%   
Share capital Rs m26817,685 1.5%   
"Free" reserves Rs m13,9350-   
Net worth Rs m14,701248,600 5.9%   
Long term debt Rs m9,478371,384 2.6%   
Total assets Rs m73,9881,001,337 7.4%  
Interest coverage x-0.43.9 -9.0%   
Debt to equity ratio x0.61.5 43.2%  
Sales to assets ratio x0.10.5 19.4%   
Return on assets %0.58.2 6.1%  
Return on equity %-27.324.2 -112.5%  
Return on capital %-6.413.6 -47.2%  
Exports to sales %25.90-   
Imports to sales %0.20-   
Net fx Rs m1,8350-   
CASH FLOW
From Operations Rs m1,71965,739 2.6%  
From Investments Rs m-3,148-51,843 6.1%  
From Financial Activity Rs m1,426-17,322 -8.2%  
Net Cashflow Rs m-3-3,427 0.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 64.78 Rs / USD

Compare STERLING BIOTECH With: ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare STERLING BIOTECH With: CIPLA  AJANTA PHARMA  SUVEN LIFE  AUROBINDO PHARMA  FDC LTD.  



Today's Market

Sensex Opens Firm; IT Stocks Gain(09:30 am)

Asian stocks were relatively subdued in the early trade today, with most regional indices hovering around the flat line following the softer lead stateside.

Related Views On News

Galaxy Surfactants Ltd. (IPO)

Jan 27, 2018

Should you subscribe to the IPO of Galaxy Surfactants Ltd?

More Views on News

Most Popular

Follow India's Super Investors to Make Big Money in the Market Crash(The 5 Minute Wrapup)

Feb 8, 2018

Has the sell-off in the markets left India's super investors unduly worried?

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

Rising Dominance of Mutual Funds(Chart Of The Day)

Feb 8, 2018

Domestic money flow into Indian equities surpassed foreign fund flows in the recent years. But will it continue in volatile market?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

STERLING BIOTECH SHARE PRICE


Feb 21, 2018 11:31 AM

TRACK STERLING BIOTECH

  • Track your investment in STERLING BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STERLING BIOTECH

STERLING BIOTECH 5-YR ANALYSIS

COMPARE STERLING BIOTECH WITH

MARKET STATS